Correction to: Mol Cancer (2018) 17:119
https://doi.org/10.1186/s12943-018-0870-5
Following publication of the original article [1], the authors identified some minor errors in image-typesetting in Figs. 3, 4 and 7. Specifically, the following panels have been corrected:
Figure 3B
Figure 4A
Figure 4D
Figure 7D
The corrected figures are given below. The corrections do not have any effect on the final conclusions of the paper.
Reference
Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119 https://doi.org/10.1186/s12943-018-0870-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liang, H., Yu, T., Han, Y. et al. Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer 20, 64 (2021). https://doi.org/10.1186/s12943-021-01344-4
Published:
DOI: https://doi.org/10.1186/s12943-021-01344-4